Rho 8 inhibitors belong to a distinct chemical class characterized by their ability to modulate the activity of Rho kinase 8 (Rho 8), a critical enzyme involved in cellular signaling pathways. Rho kinases, or ROCKs, constitute a family of serine/threonine kinases that play pivotal roles in regulating various cellular processes, including cytoskeleton dynamics, cell migration, and smooth muscle contraction. Rho 8, a specific isoform within this family, has garnered attention for its unique functions and its potential as a pharmacological target. Researchers have identified small molecules that act as inhibitors of Rho 8, disrupting its enzymatic activity and subsequently influencing downstream signaling cascades.
The chemical structure of Rho 8 inhibitors is carefully designed to interact with the active site of the Rho 8 enzyme, obstructing its catalytic function. This interference, in turn, affects the phosphorylation of target proteins involved in cellular processes such as actin-myosin contraction and focal adhesion assembly. By modulating these pathways, Rho 8 inhibitors have the potential to impact cellular behavior and function. The development and study of Rho 8 inhibitors contribute to our understanding of intracellular signaling mechanisms, providing valuable insights into the intricate regulatory networks that govern fundamental biological processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a potent inhibitor of ROCK, a Rho effector protein, thus indirectly inhibiting Rho8. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Blebbistatin inhibits myosin II ATPase, an effector in the Rho pathway, thus can influence Rho8 activity. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
ML141 is a selective inhibitor of Cdc42, a GTPase in the Rho family, and its inhibition can indirectly affect Rho8. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
NSC23766 inhibits Rac1, another Rho GTPase, potentially affecting Rho8. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $78.00 | ||
EHop-016 is a selective Rac1 inhibitor and its inhibitory effect can influence Rho8. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
ITX3 is a selective inhibitor of Trio, a Rho guanine nucleotide exchange factor (GEF), thus can indirectly inhibit Rho8. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $273.00 | 6 | |
SecinH3 inhibits cytohesin ARF GEFs, affecting the ARF-Rho8 signaling pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A inhibits ARF1, a member of the ARF family that regulates Rho GTPases, and can influence Rho8. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $61.00 $85.00 | 4 | |
Tozasertib inhibits Aurora A kinase, which can interact with Rho GTPases, thus indirectly affecting Rho8. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $39.00 $123.00 $230.00 | ||
GSK 429286 is a selective ROCK1 and ROCK2 inhibitor, affecting the downstream effects of Rho8. | ||||||